PivoxMarket Explorer
Live

MRK

2025Q3BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-10-30 · Fiscal end 2025-09-30 · Features as of 2025-10-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.35
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2025-10-29

Run-up

Close—
Ret 5d-1.2%
Ret 10d+2.9%
Ret 20d-3.9%
Ret 30d+6.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.58Beat
Estimated EPS2.35
Actual revenue
17.2B
Surprise %+9.8%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction+2.0%
Implied vs actual

Implied 1.7%Actual 2.3%

Gap reaction-2.3%
Day result-0.3%
Next-day upYes
Realized / IV1.30×

Post tape

Post 5d-0.6%
Post 10d+7.7%
Post volume16.7M
Vol ×10d1.78×
Vol ×20d1.67×
Post range4.7%